(Q42824119)

8 November 2017

The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo (English)

1 reference

8 November 2017

Yang ZY

1

1 reference

8 November 2017

Perkins ND

2

1 reference

8 November 2017

Ohno T

3

1 reference

8 November 2017

Nabel EG

4

1 reference

8 November 2017

Nabel GJ

5

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 October 1995

1 reference

8 November 2017

1 reference

8 November 2017

1

1 reference

8 November 2017

10

1 reference

8 November 2017

1052-1056

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1095-1052

8 November 2017

0 references

cites work

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

Identification of a gene necessary for cell cycle arrest by a negative growth factor of yeast: FAR1 is an inhibitor of a G1 cyclin, CLN2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

WAF1, a potential mediator of p53 tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

The retinoblastoma protein physically associates with the human cdc2 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

21 January 2018

Mitosis in transition

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Rules to replicate by

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Ordering S phase and M phase in the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

p21-containing cyclin kinases exist in both active and inactive states

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

p53-dependent apoptosis suppresses tumor growth and progression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

The retinoblastoma protein: more than a tumor suppressor

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

The E2F transcription factor is a cellular target for the RB protein

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Differential regulation of E2F transactivation by cyclin/cdk2 complexes

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Phosphate-regulated inactivation of the kinase PHO80-PHO85 by the CDK inhibitor PHO81.

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Phosphorylation of the transcription factor PHO4 by a cyclin-CDK complex, PHO80-PHO85.

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Combination gene therapy for liver metastasis of colon carcinoma in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

A model system for in vivo gene transfer into the central nervous system using an adenoviral vector.

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Gene therapy for vascular smooth muscle cell proliferation after arterial injury

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Spectrophotometric Assay of Eumelanin in Tissue Samples

1 reference

https://api.crossref.org/works/10.1038%2FNM1095-1052

7 January 2021

Identifiers

DOI

10.1038/NM1095-1052

1 reference

release_rqs7cqxt5ncrfhaiiltjcy7qga

8 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rqs7cqxt5ncrfhaiiltjcy7qga

24 November 2022

mapped directly with Wikidata item

1 reference